Dodat H, Takvorian P, Mure P Y, Canterino I, Pouillaude J M
Service de Chirurgie Pédiatrique, Hôpital Edouard-Herriot, Lyon.
Prog Urol. 1995 Feb;5(1):58-68.
This study of 785 cases of vesicorenal reflux in 494 children treated endoscopically over a 7-year period was designed to evaluate the results obtained with three products used successively: Teflon, collagen and Macroplastic. Following Teflon injection, despite a 90% short-term success rate, recurrent reflux was subsequently observed in 16.71% of the ureters reviewed. The failure rate was 52.63% after collagen injection and 11.77% after Macroplastic. After one or two injections, complete resolution of reflux was obtained in 48% of children treated with collagen, versus 85.72% with Teflon and 93.33% with Macroplastic. In one half of cases, failure was related to the quality of the product and its modifications after injection. The marked resorption of collagen accounts for the poor results despite the large doses injected. Apart from one case of partial resorption of Teflon paste, the failures with this product were due to lateralisation or secondary elimination of the product from the injection site due to its fluidity. Macroplastic, due to its higher viscosity and absence of retraction, currently provides the best results with doses of less than 0.20 ml in children.
这项针对494名儿童的785例膀胱输尿管反流的研究,在7年时间里采用内镜治疗,旨在评估先后使用的三种产品(聚四氟乙烯、胶原蛋白和Macroplastic)的治疗效果。注射聚四氟乙烯后,尽管短期成功率为90%,但随后在复查的输尿管中,16.71%出现了复发性反流。注射胶原蛋白后的失败率为52.63%,注射Macroplastic后的失败率为11.77%。在接受一到两次注射后,接受胶原蛋白治疗的儿童中48%的反流完全消失,而接受聚四氟乙烯治疗的为85.72%,接受Macroplastic治疗的为93.33%。在一半的病例中,失败与产品质量及其注射后的变化有关。尽管注射了大剂量的胶原蛋白,但由于其明显的吸收,导致效果不佳。除了一例聚四氟乙烯糊剂部分吸收的病例外,该产品的失败是由于其流动性导致产品向一侧移位或从注射部位继发排出。Macroplastic由于其较高的粘度且无回缩现象,目前在儿童中使用剂量小于0.20 ml时效果最佳。